SCHEDULE 13-D CACTUS VENTURES, INC. BHOLDEN 6.25.07

Company

Actinium Pharmaceuticals, Inc.

Filed

June 25, 2007

Accession Number

0001398137-07-000020

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →